Requires health care claims experience data to be shared with local governments.
Summary
A5046 requires health care and prescription drug claims experience data to be shared with local government employers upon written request. The bill applies to local units such as municipalities, counties, boards of education, fire districts, special districts, and related agencies. It would require carriers, third-party administrators, and other health benefits entities to provide complete claims experience data, including loss reports and large claims data, in both electronic and manual form within 60 days and at no cost to the requesting employer.
The bill also extends similar disclosure requirements to pharmacy benefits managers, who would have to provide prescription claims experience data, including claim-level prescription information, rebate amounts, and information about spread pricing practices. All disclosures must comply with HIPAA privacy requirements. The Department of Banking and Insurance would be responsible for investigating and enforcing violations, and it could compel disclosure if a violation is found. Each violation could carry a penalty of up to $5,000 per day.
Impact
The bill amends existing law governing the State Health Benefits Program and School Employees Health Benefits Program by removing the prior limitation that requests for claims experience data could be made no more than once every 24 months. It also adds new statutory requirements for carriers, third-party administrators, and pharmacy benefits managers serving local units, creating a direct legal obligation to furnish claims and prescription data on request. The Department of Banking and Insurance would gain explicit enforcement authority, and penalties would be recoverable under the Penalty Enforcement Law of 1999.
Sentiment
Based on the bill text and the absence of recorded committee testimony or votes, the overall sentiment appears to be supportive of transparency and cost oversight in public-sector health benefits administration. The bill is framed as a tool for local governments to better understand claims experience, prescription drug costs, rebates, and spread pricing, suggesting a policy goal of improving purchasing power and budget management. No recorded opposition or amendments are provided in the available materials.
Contention
The main points of potential contention are the breadth of the disclosure mandate and the compliance burden on insurers, third-party administrators, and pharmacy benefits managers. Entities subject to the bill may object to having to provide detailed claims-level and rebate information, especially where they believe data handling could raise privacy, administrative, or proprietary concerns. Another possible issue is the enforcement structure, including daily penalties and the Department of Banking and Insurance’s authority to compel disclosure. Supporters, by contrast, are likely local governments seeking greater transparency into health plan costs and pharmacy benefit practices.